AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2016
Sep 8, 2016
35124_dirs_2016-09-08_915bfd79-b11f-4229-8abd-8fac1ba1c804.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-09-06
Reporting Person: CHURCH JEFFREY WAYNE (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-06 | Option to Purchase Celsion Corporation Common Stock | $1.22 | A | 29332 | Acquired | 2026-09-06 | Celsion Corporation Common Stock (29332) | Direct |
Footnotes
F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
F2: The option vests on the date of grant.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23